Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

US Patent 9752147 · Granted Sep 5, 2017

Estimated economic value: $2,890,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2023
Devices, systems, and methods for modeling ocular translaminar pressure gradient2023
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2021
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2021
Ocular formulations for drug-delivery to the posterior segment of the eye2019
Ocular formulations for drug-delivery and protection of the anterior segment of 2019
Transferrin/transferrin receptor-mediated siRNA delivery2018
Transferrin/transferrin receptor-mediated siRNA delivery2018
Ocular formulations for drug-delivery to the posterior segment of the eye2018
Interfering RNA delivery system and uses thereof2018